Picture of Reata Pharmaceuticals logo

RETA Reata Pharmaceuticals Balance Sheet

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeLarge Cap

Annual balance sheet for Reata Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
Period Length:
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments338664818590388
Net Total Receivables22.20
Prepaid Expenses
Total Current Assets342669847596398
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment1.4512.110.1138116
Other Long Term Assets
Total Assets345682858735514
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities55.91921195459
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities330426440549580
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity15.2257417186-65.7
Total Liabilities & Shareholders' Equity345682858735514
Total Common Shares Outstanding